Equity Capital Markets

Company · CIK 1706431

Vir Biotechnology, Inc.

CIK1706431 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedVIR (Nasdaq)
First annual or quarterly report2019-11-19

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-275314
ShelfEffective
 2023-11-032026-02-263
333-250013
ShelfEffective
 2020-11-102020-11-101
333-239689
Registered companyFinal prospectus
 2020-07-062020-07-083
333-233604
IPOFinal prospectus
 2019-09-032019-10-114

Filings

13
FiledFilingRegistrationAccession
2026-02-26424B5Shelf takedown 333-2753140001193125-26-077336
2026-02-24424B5Shelf takedown 333-2753140001193125-26-067212
2023-11-03S-3ASRShelf registered 333-2753140001193125-23-270443
2020-11-10S-3ASRShelf registered 333-2500130001193125-20-290303
2020-07-08424B4Final prospectus 333-2396890001193125-20-189707
2020-07-07EFFECTDeclared effective 333-2396899999999995-20-001710
2020-07-06S-1Registration filed 333-2396890001193125-20-187304
2020-06-23DRSDraft made public 377-032400000950123-20-006355
2019-10-11424B4Final prospectus 333-2336040001193125-19-266864
2019-10-10EFFECTDeclared effective 333-2336049999999995-19-002288
2019-09-30S-1/AAmendment 333-2336040001193125-19-257981
2019-09-03S-1Registration filed 333-2336040001193125-19-236592
2019-06-27DRSDraft made public 377-027120000950123-19-006148

All filings of this company · CSV